Status:
COMPLETED
Carbohydrate Intake and Gut Hormone Release During Exercise
Lead Sponsor:
Imperial College London
Conditions:
Obesity
Eligibility:
MALE
18-40 years
Phase:
NA
Brief Summary
It is well known that following a single session of moderate-to-high intensity exercise individuals experience a temporary suppression of hunger and a delay in the commencement of eating. This effect ...
Detailed Description
It is well established that following an acute bout of moderate-to-high intensity exercise individuals experience a transient suppression of hunger and a delay in the commencement of eating - a phenom...
Eligibility Criteria
Inclusion
- Male
- Age between 18-40 years (inclusive)
- Body mass index (BMI) of 18-30 kg/m2
- Willingness and ability to give written informed consent and willingness and ability to understand, to participate and to comply with the study requirements
Exclusion
- Abnormal ECG
- Screening blood results outside of normal reference values
- Current smokers
- Current or history of substance abuse and/or excess alcohol intake
- Diabetes
- Cardiovascular disease
- Cancer
- Gastrointestinal disease e.g. inflammatory bowel disease or irritable bowel syndrome
- Kidney disease
- Liver disease
- Pancreatitis
- Started new medication within the last 3 months likely to interfere with energy metabolism, appetite regulation and hormonal balance, including: anti-inflammatory drugs or steroids, antibiotics, androgens, phenytoin, erythromycin or thyroid hormones.
- Participation in a research study in the 12 week period prior to entering this study.
- Any blood donation within the 12 week period prior to entering this study
Key Trial Info
Start Date :
February 21 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 12 2020
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04019418
Start Date
February 21 2019
End Date
February 12 2020
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial Clinical Research Facility
London, United Kingdom, W12 0HS